+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Emerging Transfusion Diagnostic Typing, Grouping and NAT Screening Tests, Country Market Shares, Strategic Profiles and Leading Reagent and Instrument Suppliers, 2019

  • ID: 4769442
  • Report
  • 225 pages
  • VPG Market Research
1 of 2

FEATURED COMPANIES

  • Abbott
  • Biokit
  • Diagast
  • Grifols
  • LabCorp
  • Quidel
  • MORE
This 225-page report presents a comprehensive analysis of the clinical significance and market needs for major transfusion diagnostic typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing innovative blood banking technologies and products.

The report also presents strategic assessments of current and emerging suppliers, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.

Contains 225 pages and 6 tables
Note: Product cover images may vary from those shown
2 of 2

Loading
LOADING...

3 of 2
  • Abbott
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • bioMerieux
  • Bio-Rad
  • Diagast
  • DiaSorin
  • Fujirebio
  • Grifols
  • Hologic
  • Immucor
  • LabCorp
  • Ortho-Clinical Diagnostics
  • Proteome Sciences
  • Quest Diagnostics
  • Quidel
  • Roche
  • Siemens Healthineers
  • Tecan
  • Thermo Fisher
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/4769442
Adroll
adroll